Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 2/2007

01-06-2007 | Original Article

Phase I/II study of IV topotecan in combination with whole brain radiation for the treatment of brain metastases

Authors: Alireza Mirmiran, Edward McClay, Matthew A. Spear, M.D.

Published in: Medical Oncology | Issue 2/2007

Login to get access
Metadata
Title
Phase I/II study of IV topotecan in combination with whole brain radiation for the treatment of brain metastases
Authors
Alireza Mirmiran
Edward McClay
Matthew A. Spear, M.D.
Publication date
01-06-2007
Publisher
Humana Press
Published in
Medical Oncology / Issue 2/2007
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/BF02698033

Other articles of this Issue 2/2007

Medical Oncology 2/2007 Go to the issue

Original Article

Inhibition of glioma cell line A-172 MMP activity and cell invasion in vitro by a nutrient mixture

Original Article

Inhibitory effects of a nutrient mixture on human testicular cancer cell line NT 2/DT matrigel invasion and MMP activity

Original

Antitumor effect of zoledronic acid in previously untreated patients with multiple myeloma

Origanal Article

Adrenomedullin expression does not correlate with survival in lung cancer

Original Article

DPYD*5 gene mutation contributes to the reduced DPYD enzyme activity and chemotherapeutic toxicity of 5-FU

Review

A general review of the role of irinotecan (CPT11) in the treatment of gastric cancer

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits